JPS5557517A - Therapy and pharmacologic medicine for occulusive respiratory tract disease and heart disease - Google Patents

Therapy and pharmacologic medicine for occulusive respiratory tract disease and heart disease

Info

Publication number
JPS5557517A
JPS5557517A JP13584479A JP13584479A JPS5557517A JP S5557517 A JPS5557517 A JP S5557517A JP 13584479 A JP13584479 A JP 13584479A JP 13584479 A JP13584479 A JP 13584479A JP S5557517 A JPS5557517 A JP S5557517A
Authority
JP
Japan
Prior art keywords
disease
occulusive
pharmacologic
therapy
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13584479A
Other languages
English (en)
Other versions
JPS6340167B2 (ja
Inventor
Gunnaa Chierin Peru
Geran Augusuto Peruson Kaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20336144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS5557517(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Draco AB filed Critical Draco AB
Publication of JPS5557517A publication Critical patent/JPS5557517A/ja
Publication of JPS6340167B2 publication Critical patent/JPS6340167B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP13584479A 1978-10-20 1979-10-19 Therapy and pharmacologic medicine for occulusive respiratory tract disease and heart disease Granted JPS5557517A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7810946A SE7810946L (sv) 1978-10-20 1978-10-20 Metod att behandla kronisk obstruktiv luftvegssjukdom

Publications (2)

Publication Number Publication Date
JPS5557517A true JPS5557517A (en) 1980-04-28
JPS6340167B2 JPS6340167B2 (ja) 1988-08-10

Family

ID=20336144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13584479A Granted JPS5557517A (en) 1978-10-20 1979-10-19 Therapy and pharmacologic medicine for occulusive respiratory tract disease and heart disease

Country Status (8)

Country Link
US (2) US4325956A (ja)
EP (2) EP0045094B1 (ja)
JP (1) JPS5557517A (ja)
AU (1) AU529805B2 (ja)
HK (1) HK71486A (ja)
IE (1) IE49623B1 (ja)
SE (1) SE7810946L (ja)
SG (1) SG32486G (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423805A2 (en) 1989-10-20 1991-04-24 Kyowa Hakko Kogyo Kabushiki Kaisha Condensed purine derivatives
TWI568943B (zh) * 2014-07-02 2017-02-01 Nsk Ltd Crown retainer and bevel ball bearing

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
US4562194A (en) * 1984-07-31 1985-12-31 Warner-Lambert Company Synergistic non-steroidal anti-inflammatory compounds and compositions thereof
SE8602887D0 (sv) * 1986-06-27 1986-06-27 Draco Ab New chemical method
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
EP0407651A3 (en) * 1989-07-10 1991-08-07 J. Uriach & Cia. S.A. Use of 1,3-diisobutyl-8-methylxanthine as a bronchodilator and antiallergy agent
WO1994019351A1 (en) * 1993-02-26 1994-09-01 Schering Corporation 2-benzyl-polycyclic guanine derivatives and process for preparing them
US6403567B1 (en) * 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
USRE47351E1 (en) 1999-06-22 2019-04-16 Gilead Sciences, Inc. 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
WO2001016134A1 (en) * 1999-08-31 2001-03-08 Vanderbilt University Selective antagonists of a2b adenosine receptors
US6815446B1 (en) 1999-08-31 2004-11-09 Vanderbilt University Selective antagonists of A2B adenosine receptors
CA2671940A1 (en) * 2000-02-23 2001-08-30 Cv Therapeutics, Inc. Identification of partial agonists of the a2a adenosine receptor
JP2005538190A (ja) * 2002-07-29 2005-12-15 シーブイ・セラピューティクス・インコーポレイテッド 心筋潅流イメージング
US20050020915A1 (en) * 2002-07-29 2005-01-27 Cv Therapeutics, Inc. Myocardial perfusion imaging methods and compositions
US8470801B2 (en) 2002-07-29 2013-06-25 Gilead Sciences, Inc. Myocardial perfusion imaging methods and compositions
CA2583185A1 (en) * 2004-10-20 2006-04-27 Cv Therapeutics, Inc. Use of a2a adenosine receptor agonists
KR101494125B1 (ko) 2006-02-03 2015-02-16 길리애드 사이언시즈, 인코포레이티드 Ａ2ａ-아데노신 수용체 효능제 및 이의 다형체의 제조 방법
RU2459626C2 (ru) * 2006-09-01 2012-08-27 Гайлид Сайэнсиз, Инк. Способы и композиции, повышающие переносимость пациентом методов визуализации миокарда
US20090081120A1 (en) * 2006-09-01 2009-03-26 Cv Therapeutics, Inc. Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
EP2066232A1 (en) * 2006-09-29 2009-06-10 Cv Therapeutics, Inc. Methods for myocardial imaging in patients having a history of pulmonary disease
WO2008086096A2 (en) * 2007-01-03 2008-07-17 Cv Therapeutics, Inc. Myocardial perfusion imaging
MX2011003168A (es) * 2008-09-29 2011-05-19 Gilead Sciences Inc Combinaciones de un agente de control de cantidad y un antagonista del receptor a-2-alfa para utilizarse en metodos de tomografia computarizada de detectores multiples.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1245969B (de) * 1967-08-03 VEB Arzneimittelwerk Dresden, Radebeul Verfahren zur Herstellung von Xanthinderivaten
GB683523A (en) 1948-08-18 1952-12-03 Beecham Res Lab The manufacture of purine derivatives
JPS53890B2 (ja) * 1972-04-22 1978-01-12
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
CA1077932A (en) * 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
US4089959A (en) * 1976-03-31 1978-05-16 Cooper Laboratories, Inc. Long-acting xanthine bronchodilators and antiallergy agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0423805A2 (en) 1989-10-20 1991-04-24 Kyowa Hakko Kogyo Kabushiki Kaisha Condensed purine derivatives
TWI568943B (zh) * 2014-07-02 2017-02-01 Nsk Ltd Crown retainer and bevel ball bearing

Also Published As

Publication number Publication date
SE7810946L (sv) 1980-04-21
AU529805B2 (en) 1983-06-23
AU5187279A (en) 1980-05-01
US4804664A (en) 1989-02-14
JPS6340167B2 (ja) 1988-08-10
EP0011609B1 (en) 1983-04-13
EP0011609A3 (en) 1980-07-23
US4325956A (en) 1982-04-20
HK71486A (en) 1986-10-03
SG32486G (en) 1989-12-22
IE791988L (en) 1980-04-20
EP0045094A1 (en) 1982-02-03
EP0011609B2 (en) 1988-05-11
IE49623B1 (en) 1985-11-13
EP0045094B1 (en) 1984-05-16
EP0011609A2 (en) 1980-05-28

Similar Documents

Publication Publication Date Title
JPS5557517A (en) Therapy and pharmacologic medicine for occulusive respiratory tract disease and heart disease
GB2096467B (en) Medical instrument for introduction into the respiratory tract of a patient
JPS5540595A (en) Medicine inhaler
GB2017312B (en) Apparatus for detecting the activity of the respiratory organs and the heart of a living being
NZ195766A (en) Inhalation device for administration of powered medicament
GB8326878D0 (en) Administering medicaments to patients
GB8602264D0 (en) Administering medicaments to patients
SE7610356L (sv) Spirometer for anslutning till en patients andningsvegar
JPS5555113A (en) Oral administration medical tablet and its manufacture
JPS55147223A (en) Pharmaceutical medicine
GB2073589B (en) Diagnostic and therapeutic radio pharmaceutical capsules
BE874912A (fr) Dispositif pour realiser la respiration artificielle de patients
JPS57131721A (en) Drug treatment for body disease
JPS5585524A (en) Respiratory tract vaccine and its manufacture
JPS57114508A (en) Pharmaceutical medicine for use of choline- action suppressive drug
JPS57139016A (en) Burn patient medicine
SG785G (en) Drug combination for the treatment of infectious diseases of the respiratory tract
JPS54141797A (en) Therapeutic drug
BE876164A (fr) Medicament contre des maladies infectieuses des voies respiratoires
GB1547036A (en) Apparatus for the infusion of a labour-inducing drug into bloodstream of a patient
JPS56100054A (en) Technique of dental medicine
JPS5259167A (en) 1*44benzodioxane and medicines for circulatory disease and asthma
JPS54160398A (en) Quinolopyranee44onee22carboxylic acid ester derivative and antiiallergic asthma therapeutic medicine
DE3173229D1 (en) Inhalation spirometric device for administering pulmonary medication
JPS54141800A (en) 8 betaahydrazinomethyllergolene derivative* its manufacture and medical drug containing it